Vancomycin Purification Guide

Glycopeptide antibiotic from Amycolatopsis orientalis — MW 1,449 Da, amphoteric (pI 7.2), complex multi-ring structure

Physical Properties

Molecular Weight
1,449.3 Da
Molecular Formula
C66H75Cl2N9O24
Solubility (Water)
~225 g/L
Isoelectric Point (pI)
7.2
Density
~1.4 g/cm³
pKa Values
2.18, 7.75, 8.89, 9.59, 10.4, 12.0
Charge (pH 5)
+2
Charge (pH 7.2)
~0 (pI)
UV Absorption
λmax 280 nm
Typical Concentration
5–20 g/L
Stability
pH 3–8, <40°C
Sugar Moiety
Vancosamine + Glucose

Recommended Separation Techniques

Ranked by effectiveness for vancomycin recovery from Amycolatopsis orientalis fermentation broths.

Reverse Phase HPLC (RP-HPLC) Best Match

The gold standard for vancomycin purification. C18 or C8 columns with acetonitrile–water gradients containing 0.1% TFA achieve baseline separation of vancomycin from its closely related impurities (CDP-1, crystalline degradation products). At MW 1,449 Da, vancomycin is within the ideal range for RP chromatography (unlike large proteins that denature). Purity >95% (USP specification). Recovery: 80–90%.

Ion Exchange Chromatography Best Match

Vancomycin is amphoteric with 6 ionizable groups. At pH 5.0, it carries +2 charge, binding strongly to cation exchange resins (SP Sepharose, CM cellulose). Elution with NaCl gradient. Separates vancomycin from neutral and anionic impurities with high capacity. Used as capture step before RP-HPLC polishing. Recovery: 85–95%.

Crystallization Good

Vancomycin hydrochloride crystallizes from concentrated aqueous solutions by anti-solvent addition (acetone, isopropanol). Cooling crystallization from water also works at high concentrations (>150 g/L). Produces pharmaceutical-grade crystalline material. Often used as the final processing step to achieve desired solid form and particle size distribution.

Nanofiltration (NF) Good

At MW 1,449 Da, vancomycin is well retained by tight NF membranes (200–500 Da MWCO) while small-molecule impurities (salts, amino acids, sugars <500 Da) pass through. Used for concentration and desalting after chromatographic steps. Diafiltration with NF removes 95–99% of small-molecule impurities. Also used for initial broth clarification and concentration.

Common Impurity Separations

Separate From Key Difference Best Technique Selectivity Basis
CDP-1 (Related Impurity) Hydrophobicity (deaminated variant) RP-HPLC Retention time difference
Fermentation Byproducts MW (1,449 Da vs variable), charge Ion Exchange / NF Charge & size
Cells / Biomass Size (1,449 Da vs micron-scale cells) Centrifugation / MF Size exclusion
Salts / Buffer Components MW (1,449 Da vs <200 Da) NF / Diafiltration Molecular weight cutoff

Ionization & pH-Dependent Behavior

Vancomycin has six ionizable groups, making its charge state highly pH-dependent. This complexity is both a challenge and an opportunity for separation design.

Ionizable Groups

pKa 2.18: Carboxyl group (C-terminal leucine). Below pH 2.18: protonated (neutral). Above: deprotonated (−1).

pKa 7.75, 8.89: Two phenolic hydroxyl groups on the aromatic rings. Deprotonate at alkaline pH.

pKa 9.59, 10.4, 12.0: Primary amine (vancosamine sugar), secondary amine, and additional phenolic group. Carry positive charge at acidic/neutral pH.

Net Charge vs pH

pH RangeNet ChargeSeparation Strategy
pH 3.0+3Strong cation exchange binding
pH 5.0+2CEX capture (standard condition)
pH 7.2~0 (pI)Minimal charge — crystallization, RP-HPLC
pH 9.0−2Anion exchange binding possible

Frequently Asked Questions

What is CDP-1 and why is it hard to remove from vancomycin?

CDP-1 (Crystalline Degradation Product 1) is the major related impurity of vancomycin, formed by asparagine deamidation to aspartate in the vancomycin backbone. It has nearly identical molecular weight (1,450 vs 1,449 Da) and charge properties. Only RP-HPLC can reliably resolve vancomycin from CDP-1, exploiting a subtle hydrophobicity difference. USP monograph requires CDP-1 < 4.0%. Process design must minimize degradation (low temperature, controlled pH) and include RP-HPLC for final polishing.

How is vancomycin purified industrially?

The standard industrial process begins with removal of Amycolatopsis orientalis cells by filtration or centrifugation. The clarified broth is concentrated by NF or evaporation, then loaded onto cation exchange resin at pH 5.0. Eluted vancomycin is further purified by RP-HPLC to remove CDP-1 and other closely related impurities. Final crystallization from water–acetone produces vancomycin HCl powder for lyophilization. Design your route with untangle.bio.

Can vancomycin be purified by ultrafiltration?

At 1,449 Da, vancomycin sits in a challenging range for UF membranes. Standard UF membranes (10–30 kDa MWCO) pass vancomycin freely, useful for separating it from proteins and cell debris. Tight NF membranes (200–500 Da MWCO) retain vancomycin while passing salts and small metabolites. NF is commonly used for concentration and desalting but cannot resolve vancomycin from similar-sized impurities like CDP-1.

Why does vancomycin require RP-HPLC rather than simpler techniques?

The critical impurities (CDP-1, minor variants) differ from vancomycin by only 1 Da or a single functional group change. Ion exchange, NF, and crystallization cannot resolve these closely related species. Only RP-HPLC, with its high theoretical plate count and fine selectivity for hydrophobic differences, achieves the >95% B-type vancomycin purity required by pharmacopeial specifications (USP, EP).

Design Your Vancomycin Purification Process

Build and simulate complete downstream processing routes with real mass balance and cost estimation.

Open untangle.bio